Country-wise biosimilar pipelines number in development worldwide 2017

Number of biosimilars in development worldwide as of October 2017, by country

by Matej Mikulic, last edited Apr 24, 2018
Country-wise biosimilar pipelines number in development worldwide 2017 This statistic displays the Number of biosimilars in development worldwide as of October 2017, by country. China had 269 biosimilars in development, which was the largest number, followed by India with 257 biosimilars in development.
Show more

Number of biosimilars in development worldwide as of October 2017, by country

Loading statistic...
Number of biosimilars
China269
India257
United States187
South Korea109
Russia97
Switzerland57
Argentina48
Japan45
Brazil37
Number of biosimilars
China269
India257
United States187
South Korea109
Russia97
Switzerland57
Argentina48
Japan45
Brazil37
Download Settings Share
Download started
Please be patient - this may take a moment
by Matej Mikulic, last edited Apr 24, 2018
This statistic displays the Number of biosimilars in development worldwide as of October 2017, by country. China had 269 biosimilars in development, which was the largest number, followed by India with 257 biosimilars in development.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Generics and biosimilars
Generics and biosimilars

All Information
in one Presentation

Generics and biosimilars

Everything On "Generics and biosimilars" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Generics and biosimilars"
  • Global overview
  • Top companies
  • U.S. market
  • Patent expiration
  • Savings
  • Biosimilars
The most important statistics
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.